Abingdon Health Ltd, is pleased to announce that it has appointed Biomedical Diagnostics (“BMD”) as exclusive distributor for Belgium, The Netherlands and Luxembourg (“Benelux”) for the Seralite® – FLC rapid diagnostic test.
Seralite® – FLC is a rapid diagnostic device for the quantitative measurement of kappa (K) and lambda (λ) immunoglobulin free light chains (FLCs) in serum as an aid to the diagnosis and management of multiple myeloma. The assay provides an accurate picture of disease status in 10 minutes. The simple to use, portable, rapid test allows the monitoring of patients in “real time” supporting faster decision making. By obtaining results rapidly, clinicians are able to better understand disease status and can make informed treatment decisions quickly and efficiently.
The full press release can be found at www.abingdonhealth.com/biomedical-diagnostics-appointed-as-seralite-flc-distributor/